Skip to main content

Table 1 Patient characteristics

From: Epidemiological characteristics and gender-specific differences of obstructive sleep apnea in a Chinese hypertensive population: a cross-sectional study

Variables Without OSA With OSA P value
N (%) 286 (29.5) 685 (70.5)  
Age (years) 56.5 ± 13.3 59.3 ± 11.7 0.001
Male (%) 71.7 78.4 0.016
BMI (Kg/m2) 24.6 ± 3.6 25.8 ± 4.1 <0.001
SBP (mm Hg) 137.3 ± 20.4 137.4 ± 21.5 0.975
DBP (mm Hg) 79.3 ± 13.6 79.4 ± 14.3 0.926
AHI 1.7 ± 1.4 22.0 ± 16.7 0.001
IVS (mm) 10.7 ± 1.8 11.4 ± 2.3 <0.001
LVPW (mm) 10.2 ± 1.8 10.5 ± 1.8 0.007
HbA1c (%) 6.1 ± 1.1 6.3 ± 1.2 0.029
Creatinine (μmol/L) 91.6 ± 48.0 99.0 ± 65.9 0.098
BUN (mmol/L) 5.5 ± 3.2 5.8 ± 2.8 0.162
FPG (mmol/L) 6.2 ± 2.6 6.5 ± 3.0 0.130
Triglyceride (mmol/L) 1.9 ± 0.3 1.8 ± 0.1 0.582
Total cholesterol (mmol/L) 4.5 ± 1.3 4.5 ± 1.2 0.643
LDL-C (mmol/L) 2.7 ± 1.0 2.7 ± 1.0 0.939
HDL-C (mmol/L) 1.0 ± 0.3 1.0 ± 0.2 0.961
Proteinuria (%) 17.1 20.4 0.183
Diabetes mellitus (%) 19.6 24.4 0.061
Dyslipidemia (%) 10.5 14.6 0.052
Aortic dissection (%) 20.3 19.9 0.472
Aneurysm (%) 4.5 5.4 0.354
CHD (%) 37.4 41.9 0.110
Cerebrovascular disease (%) 6.6 9.9 0.063
Heart failure (%) 19.2 21.9 0.200
Atrial fibrillation (%) 8.4 9.1 0.424
HCM (%) 1.7 3.4 0.121
Anti-platelet (%) 49.0 54.3 0.073
Statins (%) 59.1 66.9 0.013
ACEI (%) 22.0 22.0 0.534
ARB (%) 49.7 46.0 0.165
Beta-blocker (%) 59.4 66.4 0.023
Alpha-blocker (%) 6.6 6.4 0.500
CCB (%) 55.2 57.1 0.324
Diuretic (%) 16.1 18.7 0.192
Warfarin (%) 6.6 7.2 0.448
  1. Denote: BUN blood uria nitrogen, LDL-C low-density lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol, CHD coronary heart disease, HCM hypertrophy cardiomyopahty, ACEI angiotensin converting enzyme inhibitor, ARB angiotensin receptor blocker, CCB calcium channel blocker